These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 24965278)

  • 1. Grey matter alterations in patients with Pantothenate Kinase-Associated Neurodegeneration (PKAN).
    Rodriguez-Raecke R; Roa-Sanchez P; Speckter H; Fermin-Delgado R; Perez-Then E; Oviedo J; Stoeter P
    Parkinsonism Relat Disord; 2014 Sep; 20(9):975-9. PubMed ID: 24965278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Missense PANK2 mutation without "eye of the tiger" sign: MR findings in a large group of patients with pantothenate kinase-associated neurodegeneration (PKAN).
    Delgado RF; Sanchez PR; Speckter H; Then EP; Jimenez R; Oviedo J; Dellani PR; Foerster B; Stoeter P
    J Magn Reson Imaging; 2012 Apr; 35(4):788-94. PubMed ID: 22127788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes of cerebral white matter in patients suffering from Pantothenate Kinase-Associated Neurodegeneration (PKAN): A diffusion tensor imaging (DTI) study.
    Stoeter P; Roa-Sanchez P; Speckter H; Perez-Then E; Foerster B; Vilchez C; Oviedo J; Rodriguez-Raecke R
    Parkinsonism Relat Disord; 2015 Jun; 21(6):577-81. PubMed ID: 25819806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Motor activation in patients with Pantothenate-Kinase Associated Neurodegeneration: a functional magnetic resonance imaging study.
    Stoeter P; Rodriguez-Raecke R; Vilchez C; Perez-Then E; Speckter H; Oviedo J; Roa-Sanchez P
    Parkinsonism Relat Disord; 2012 Nov; 18(9):1007-10. PubMed ID: 22682757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pantothenate-kinase associated neurodegeneration (PKAN) "eye of the tiger" sign.
    Renaud DL; Kotagal S
    Pediatr Neurol; 2007 Jan; 36(1):70-1. PubMed ID: 17162204
    [No Abstract]   [Full Text] [Related]  

  • 6. Brain structural differences associated with the behavioural phenotype in children with Williams syndrome.
    Campbell LE; Daly E; Toal F; Stevens A; Azuma R; Karmiloff-Smith A; Murphy DG; Murphy KC
    Brain Res; 2009 Mar; 1258():96-107. PubMed ID: 19118537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Idiopathic basal ganglia calcifications: an atypical presentation of PKAN.
    Wu YW; Hess CP; Singhal NS; Groden C; Toro C
    Pediatr Neurol; 2013 Nov; 49(5):351-4. PubMed ID: 23968566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pantothenate kinase-associated neurodegeneration in Korea: recurrent R440P mutation in PANK2 and outcome of deep brain stimulation.
    Lim BC; Ki CS; Cho A; Hwang H; Kim KJ; Hwang YS; Kim YE; Yun JY; Jeon BS; Lim YH; Paek SH; Chae JH
    Eur J Neurol; 2012 Apr; 19(4):556-61. PubMed ID: 22103354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and genetic features of PKAN patients in a tertiary centre in Turkey.
    Akcakaya NH; Iseri SU; Bilir B; Battaloglu E; Tekturk P; Gultekin M; Akar G; Yigiter R; Hanagasi H; Alp R; Cagirici S; Eraksoy M; Ozbek U; Yapici Z
    Clin Neurol Neurosurg; 2017 Mar; 154():34-42. PubMed ID: 28113101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The eye-of-the-tiger sign is not a reliable disease marker for Hallervorden-Spatz syndrome.
    Baumeister FA; Auer DP; Hörtnagel K; Freisinger P; Meitinger T
    Neuropediatrics; 2005 Jun; 36(3):221-2. PubMed ID: 15944911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance imaging, susceptibility weighted imaging and quantitative susceptibility mapping findings of pantothenate kinase-associated neurodegeneration.
    Zeng J; Xing W; Liao W; Wang X
    J Clin Neurosci; 2019 Jan; 59():20-28. PubMed ID: 30392836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical pantothenate kinase-associated neurodegeneration with PANK2 mutations : clinical description and a review of the literature.
    Pan S; Zhu C
    Neurocase; 2020 Jun; 26(3):175-182. PubMed ID: 32310012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Harmful Iron-Calcium Relationship in Pantothenate kinase Associated Neurodegeneration.
    Santambrogio P; Ripamonti M; Paolizzi C; Panteghini C; Carecchio M; Chiapparini L; Raimondi M; Rubio A; Di Meo I; Cozzi A; Taverna S; De Palma G; Tiranti V; Levi S
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32456086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffusion tensor MR imaging in children with pantothenate kinase-associated neurodegeneration with brain iron accumulation and their siblings.
    Awasthi R; Gupta RK; Trivedi R; Singh JK; Paliwal VK; Rathore RK
    AJNR Am J Neuroradiol; 2010 Mar; 31(3):442-7. PubMed ID: 19850762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel homozygous PANK2 mutation causing atypical pantothenate kinase-associated neurodegeneration (PKAN) in a Cypriot family.
    Tanteles GA; Spanou-Aristidou E; Antoniou C; Christophidou-Anastasiadou V; Kleopa KA
    J Neurol Sci; 2014 May; 340(1-2):233-6. PubMed ID: 24655737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral and cerebellar white matter tract alterations in patients with Pantothenate Kinase-Associated Neurodegeneration (PKAN).
    Rivera D; Roa-Sanchez P; Bidó P; Speckter H; Oviedo J; Stoeter P
    Parkinsonism Relat Disord; 2022 May; 98():1-6. PubMed ID: 35395584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pantothenate kinase-associated neurodegeneration: insights from a Drosophila model.
    Wu Z; Li C; Lv S; Zhou B
    Hum Mol Genet; 2009 Oct; 18(19):3659-72. PubMed ID: 19602483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Siblings with the adult-onset slowly progressive type of pantothenate kinase-associated neurodegeneration and a novel mutation, Ile346Ser, in PANK2: clinical features and (99m)Tc-ECD brain perfusion SPECT findings.
    Doi H; Koyano S; Miyatake S; Matsumoto N; Kameda T; Tomita A; Miyaji Y; Suzuki Y; Sawaishi Y; Kuroiwa Y
    J Neurol Sci; 2010 Mar; 290(1-2):172-6. PubMed ID: 20006850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pantothenate kinase-associated neurodegeneration (PKAN): molecular confirmation of a Turkish patient with a rare frameshift mutation in the coding region of the PANK2 gene.
    Cangül H; Ozdemir O; Yakut T; Okan M; Morgan NV; Baytan B; Kurian MA; Spiegel R; Maher ER
    Turk J Pediatr; 2009; 51(2):161-5. PubMed ID: 19480328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PKAN neurodegeneration and residual PANK2 activities in patient erythrocytes.
    Werning M; Müllner EW; Mlynek G; Dobretzberger V; Djinovic-Carugo K; Baron DM; Prokisch H; Büchner B; Klopstock T; Salzer U
    Ann Clin Transl Neurol; 2020 Aug; 7(8):1340-1351. PubMed ID: 32705819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.